Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 8
Results: 28
Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta‑analysis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2367, doi. 10.1007/s00262-021-02868-w
- By:
- Publication type:
- Article
Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2339, doi. 10.1007/s00262-021-02867-x
- By:
- Publication type:
- Article
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2301, doi. 10.1007/s00262-021-02864-0
- By:
- Publication type:
- Article
miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2247, doi. 10.1007/s00262-021-02862-2
- By:
- Publication type:
- Article
Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2401, doi. 10.1007/s00262-021-02861-3
- By:
- Publication type:
- Article
CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2353, doi. 10.1007/s00262-021-02859-x
- By:
- Publication type:
- Article
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2323, doi. 10.1007/s00262-021-02858-y
- By:
- Publication type:
- Article
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2125, doi. 10.1007/s00262-021-02857-z
- By:
- Publication type:
- Article
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2209, doi. 10.1007/s00262-021-02855-1
- By:
- Publication type:
- Article
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2197, doi. 10.1007/s00262-021-02851-5
- By:
- Publication type:
- Article
CAR19/22 T cell therapy in adult refractory Burkitt's lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2379, doi. 10.1007/s00262-021-02850-6
- By:
- Publication type:
- Article
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2261, doi. 10.1007/s00262-021-02848-0
- By:
- Publication type:
- Article
The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2313, doi. 10.1007/s00262-021-02847-1
- By:
- Publication type:
- Article
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2151, doi. 10.1007/s00262-020-02844-w
- By:
- Publication type:
- Article
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2103, doi. 10.1007/s00262-020-02842-y
- By:
- Publication type:
- Article
Therapeutic vaccination targeting CD40 and TLR3 controls melanoma growth through existing intratumoral CD8 T cells without new T cell infiltration.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2139, doi. 10.1007/s00262-020-02841-z
- By:
- Publication type:
- Article
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2291, doi. 10.1007/s00262-020-02839-7
- By:
- Publication type:
- Article
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2389, doi. 10.1007/s00262-020-02837-9
- By:
- Publication type:
- Article
Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2275, doi. 10.1007/s00262-020-02835-x
- By:
- Publication type:
- Article
Immunotherapy response modeling by ex-vivo organ culture for lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2223, doi. 10.1007/s00262-020-02828-w
- By:
- Publication type:
- Article
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2411, doi. 10.1007/s00262-020-02824-0
- By:
- Publication type:
- Article
Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2165, doi. 10.1007/s00262-020-02816-0
- By:
- Publication type:
- Article
Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2385, doi. 10.1007/s00262-020-02815-1
- By:
- Publication type:
- Article
Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2179, doi. 10.1007/s00262-020-02792-5
- By:
- Publication type:
- Article
LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2235, doi. 10.1007/s00262-020-02753-y
- By:
- Publication type:
- Article